FDA Investigator: Anissa M. Vargas

- Anissa M. Vargas first started conducting FDA inspections in 2005, with the last inspection in 2020. Over that time, Anissa M. Vargas has conducted 22 inspections at 21 companies across 21 sites.

Get Anissa Vargas's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Bend Research, Inc., Bend | 2020

Out-of-stock
Anissa M. Vargas
Human Drug Form 483

FDA 483 Akzo Nobel Chemicals, S.A. de C.V., Los Reyes La Paz, Edo. Mex. | 2011

Out-of-stock
Anissa M. Vargas
Human Drug Form 483

FDA 483 Hubei Biocause Development Pharmaceutical Co., Ltd., Jingmen City, Hubei Province | 2010

Out-of-stock
Anissa M. Vargas
Human Drug Form 483

FDA 483 Aventis Pharma Mfg. Private Limited (Sanofi Aventis), Singapore | 2010

Out-of-stock
Anissa M. Vargas
Human Drug Form 483

FDA 483 Sintenovo SA de CV, Naucalpan De Juarez, C.P. 53370 | 2010

Out-of-stock
Anissa M. Vargas
Animal Drugs & Feed Form 483

FDA 483 Instituto Massone S.A., Buenos Aires | 2010

Out-of-stock
Anissa M. Vargas
Human Drug Form 483

FDA 483 SPI Pharma, SAS, Septemes Les Vallons | 2009

Out-of-stock
Anissa M. Vargas
Human Drug Form 483

FDA 483 Boehringer Ingelheim Labso, Blanquefort Cedex | 2009

Out-of-stock
Anissa M. Vargas
Human Drug Form 483

FDA 483 Confab Laboratories Inc., Saint-Hubert | 2009

Out-of-stock
Anissa M. Vargas
Human Drug Form 483